Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H19BrN4O2 |
Molecular Weight | 439.305 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)CC[C@@H]1N=C(C2=NC=CC=C2)C3=CC(Br)=CC=C3N4C(C)=CN=C14
InChI
InChIKey=CYHWMBVXXDIZNZ-KRWDZBQOSA-N
InChI=1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3/t17-/m0/s1
Molecular Formula | C21H19BrN4O2 |
Molecular Weight | 439.305 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:45:22 UTC 2023
by
admin
on
Sat Dec 16 17:45:22 UTC 2023
|
Record UNII |
7V4A8U16MB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
2846
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9232
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
C522201
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
100000164312
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
HI-112
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
C152187
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
m12208
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
REMIMAZOLAM
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
DTXSID20953024
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
2383941
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
7V4A8U16MB
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
9867812
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
DB12404
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
SUB178714
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
7V4A8U16MB
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY | |||
|
308242-62-8
Created by
admin on Sat Dec 16 17:45:23 UTC 2023 , Edited by admin on Sat Dec 16 17:45:23 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||